Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:
Viking Therapeutics stock rose 87% on results for its liver disease drug — and the company has more in store this fall
España Noticias Noticias
The company’s midstage clinical trial had positive results, and the condition in question affects an estimated 100 million people in the U.S.